{
  "ticker": "TAL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971769",
  "id": "02971769",
  "pages": 12,
  "price_sensitive": true,
  "date": "20250723",
  "time": "0921",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m1rptzrc5vnd.pdf",
  "summary": "### Quarterly Report (Appendix 4C) Summary:  \n- **Net profit**: $0.37M for Q2 (unaudited).  \n- **Cash receipts**: $1.82M (Q2), $4.18M (H1FY25).  \n- **Cash balance**: $2.07M at quarter-end.  \n- **Revenue**: $2.88M (Q2).  \n- **Subscriptions**: 49,300 (+6% QoQ); 12,000 pending activation.  \n- **Annual Recurring Revenue (ARR)**: $3.2M (+2% QoQ, +32% YoY).  \n- **R&D tax refund**: $0.738M (received July 2025, recognized in June).  \n- **Committed orders**: $410K (HHSTJ), $200K (Roshana Aged Care), $256K (New Direction Care), $76K (Hyecorp).  \n- **Strategic partnerships**:  \n  - Wesco Anixter distribution agreement (Australia/NZ/Singapore).  \n  - Silverchain Group AI Voice Virtual Assistant deployment.  \n  - MOU with UK\u2019s Silvercircle for potential European expansion.  \n- **Share consolidation**: 10:1 completed (effective 13 June 2025).  \n\n**Cash Flow Highlights**:  \n- **Operating cash outflow**: $2.4M (60% inventory/costs, 32.8% R&D/staff).  \n- **Financing**: Repaid $23K borrowings, $20K lease liabilities.  \n\n**Material Catalyst**: Aged Care Bill 2024 (effective 1 Nov 2025) to fund assistive technology, benefiting Talius\u2019 PERS devices.  \n\n*No material capital raising or trading halt info identified.*",
  "usage": {
    "prompt_tokens": 6867,
    "completion_tokens": 378,
    "total_tokens": 7245,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-22T23:34:10.040414"
}